The Food and Drug Administration has approved Pfizer-BioNTech’s COVID-19Shot for children aged 5-11 years, opening the door to 28 million kids to be vaccinated in America.

On Friday, the federal agency gave its approval for emergency use. The Centers for Disease Control and Prevention’s vaccine advisory committee will next meet to review the FDA’s decision on Nov 2-3. It’s expected to recommend it shortly after.

The FDA’s decision comes after an advisory panel for the agency decided unanimously that the vaccine’s benefits for children outweigh any potential risks.

“Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” said acting FDA Commissioner Janet Woodcock in a press release. “Our comprehensive and rigorous evaluation of the data pertaining to the vaccine’s safety and effectiveness should help assure parents and guardians that this vaccine meets our high standards.”

Pfizer’s vaccine had already been approved for children ages 12 to 15 on an emergency use basis, an approval that was made in May.

Pfizer stated that their smaller and more pediatric-friendly coronavirus vaccine was safe. nearly 91% effective At preventing symptoms in children aged 5-11 years old. Most common side effects were headache, fatigue, muscle pain, chills and muscle soreness. This is similar to side effects seen in older children as well as adults.

Pfizer’s vaccine requires two doses that are administered three weeks apart. The full protection will kick in after two weeks.

The White House has said that it has purchased enough doses, as well as smaller, child-sized needles, to vaccinate all of the nation’s 5- to 11-year-olds.

“The U.S. Department of Health and Human Services is working hand-in-hand with states to make this vaccine supply available in communities across the country as rapidly as possible,” the White House saidLast week.

This story is still in development. Keep checking back for more updates.

Source: HuffPost.com.

Share Your Comment Below

LEAVE A REPLY

Please enter your comment!
Please enter your name here